Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A pharmacogenetic approach to blood pressure in Lyon hypertensive rats. A chromosome 2 locus influences the response to a calcium antagonist.
M Vincent, … , G M Lathrop, J Sassard
M Vincent, … , G M Lathrop, J Sassard
Published October 15, 1997
Citation Information: J Clin Invest. 1997;100(8):2000-2006. https://doi.org/10.1172/JCI119731.
View: Text | PDF
Research Article

A pharmacogenetic approach to blood pressure in Lyon hypertensive rats. A chromosome 2 locus influences the response to a calcium antagonist.

  • Text
  • PDF
Abstract

Research Article

Authors

M Vincent, N J Samani, D Gauguier, J R Thompson, G M Lathrop, J Sassard

×

Total citations by year

Year: 2022 2021 2017 2014 2009 2006 2005 2004 2003 2002 2001 2000 1999 1998 Total
Citations: 1 1 1 1 1 1 2 2 1 3 4 4 5 3 30
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (30)

Title and authors Publication Year
Body Composition and Metabolic Changes in a Lyon Hypertensive Congenic Rat and Identification of Ercc6l2 as a Positional Candidate Gene.
Clark KC, Wagner VA, Holl KL, Reho JJ, Tutaj M, Smith JR, Dwinell MR, Grobe JL, Kwitek AE
Frontiers in Genetics 2022
Editorial: Multi-Omics Study in Revealing Underlying Pathogenesis of Complex Diseases: A Translational Perspective
YM Zhang, YF Wang, H Rasheed, J Ott
Frontiers in Genetics 2021
Towards Precision Medicine for Hypertension: A Review of Genomic, Epigenomic, and Microbiomic Effects on Blood Pressure in Experimental Rat Models and Humans
S Padmanabhan, B Joe
Physiological reviews 2017
Influence of autoantibodies against AT1 receptor and AGTR1 polymorphisms on candesartan-based antihypertensive regimen
Y Sun, Y Liao, Y Yuan, L Feng, S Ma, F Wei, M Wang, F Zhu
Journal of the American Society of Hypertension 2014
Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle
MR Freitas, M Eto, JA Kirkbride, C Schott, J Sassard, JC Stoclet
Fundamental & Clinical Pharmacology 2009
Principles of Molecular Medicine
MS Runge, C Patterson
2006
A quantitative trait locus for aortic smooth muscle cell number acting independently of blood pressure: implicating the angiotensin receptor AT1B gene as a candidate
J Dutil, V Eliopoulos, ÉL Marchand, AM Devlin, J Tremblay, K Prithiviraj, P Hamet, A Migneault, D deBlois, AY Deng
Physiological genomics 2005
Severe hypertension caused by alleles from normotensive Lewis for a quantitative trait locus on chromosome 2
V Eliopoulos, J Dutil, Y Deng, M Grondin, AY Deng
Physiological genomics 2005
Pharmacogenomics in Cardiovascular Medicine
JF Carlquist, JL Anderson
Drug Development Research 2004
Pharmacogenetics of Antihypertensive Drug Responses:
GL Schwartz, ST Turner
American Journal of PharmacoGenomics 2004
Genetics of blood pressure, hypertensive complications, and antihypertensive drug responses
ST Turner, E Boerwinkle
Pharmacogenomics 2003
Optimal blood pressure control and antihypertensive regimens in hypertensive renal disease: the potential of exploring the mechanisms of response variability
MJ Kocks, D Zeeuw, GJ Navis
Current Opinion in Nephrology and Hypertension 2002
Reciprocal rat chromosome 2 congenic strains reveal contrasting blood pressure and heart rate QTL
A Alemayehu, L Breen, D Krenova, MP Printz
Physiological genomics 2002
Rat genetics: attachign physiology and pharmacology to the genome
HJ Jacob, AE Kwitek
Nature Reviews Genetics 2002
Antihypertensive pharmacogenetics: getting the right drug into the right patient
ST Turner, GL Schwartz, AB Chapman, WD Hall, E Boerwinkle
Journal of Hypertension 2001
Use of gene markers to guide antihypertensive therapy
ST Turner, GL Schwartz, AB Chapman, E Boerwinkle
Current Hypertension Reports 2001
Further chromosomal mapping of a blood pressure QTL in Dahl rats on chromosome 2 using congenic strains
J Dutil, AY Deng
Physiological genomics 2001
Altered Na + -K + pump activity and plasma lipids in salt-hypertensive Dahl rats: relationship to Atp1a1 gene
J Zicha, CD Negrin, Z Dobešová, F Carr, M Vokurková, MA McBRIDE, J Kuneš, AF Dominiczak
Physiological genomics 2001
Genetic Analysis of Inherited Hypertension in the Rat
JP Rapp
Physiological reviews 2000
Pharmacogenetics: Promise and Potential in Child and Adolescent Psychiatry
GM Anderson, EH Cook
Child and Adolescent Psychiatric Clinics of North America 2000
Genetics of Hypertension, Target-Organ Complications, and Response to Therapy
ST Turner, E Boerwinkle
Circulation 2000
The Genomics of Cardiovascular Disorders: Therapeutic Implications
P Ferrari, G Bianchi
Drugs 2000
Gene-environment interactions in hypertension
Z Pausova, J Tremblay, P Hamet
Current Hypertension Reports 1999
Use of animal models to search for candidate genes associated with essential hypertension
M Knoblauch, K Lindpaintner
Current Hypertension Reports 1999
Genes and Hypertension: Where we are and where we Should Go
P Hamet
Clinical and Experimental Hypertension 1999
Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension
SN Orlov, NC Adragna, VA Adarichev, P Hamet
American journal of physiology. Cell physiology 1999
Genomics and Hypertension: Concepts, Potentials, and Opportunities
RE Pratt, VJ Dzau
Hypertension 1999
In search of hypertension genes in Dahl salt-sensitive rats
AY Deng
Journal of Hypertension 1998
Genetics of experimental hypertension
AF Dominiczak, JS Clark, B Jeffs, NH Anderson, CD Negrin, WK Lee, MJ Brosnan
Journal of Hypertension 1998
Pharmacogenomics
P Ferrari
Current Opinion in Nephrology and Hypertension 1998

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts